NewsRoom Articles - Page 20 of 214

FridayFeb 21, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Focuses Innovation on Hard-to-Treat Tumors

As cancer numbers grow, Calidi Biotherapeutics is at the forefront of developing novel treatments aimed at improving patient outcomes. Calidi’s platform centers on the use of antitumor virotherapies that selectively infect and kill cancer cells while activating the body’s own immune system to attack the tumor. The company’s therapeutic pipeline targets multiple cancer indications, with a focus on hard-to-treat tumors. Cancer remains a significant global health challenge, with certain types exhibiting particularly high mortality rates. Glioblastoma multiforme (“GBM”), triple-negative breast cancer (“TNBC”), sarcoma and lung cancer are among the most aggressive and deadly forms, necessitating urgent advancements in research and…

FridayFeb 21, 2025 10:00 am

Europe is Facing a Growing Shortfall of General Practitioners

Data shows that Europe is facing a growing deficit of doctors across all specialties, and the declining number of general practitioners stands out strongly. Current GPs aren’t evenly distributed and the fact that they are aging and leaving active service makes the problem worse. Traditionally, GPs have served as the first point of contact when someone is facing a health challenge. These professionals handle most patients and refer those who need additional care to specialists. This primary healthcare role has earned them the tag ‘family doctor.’ However, countries across Europe are faced with a double whammy; their general populations are…

FridayFeb 21, 2025 10:00 am

How Adageis’ ProActive Care Approach Puts Patients First While Boosting Provider Revenue

Shifting to value-based care improves patient outcomes and cost-effective provider efficiency. Adageis’ ProActive Care shifts focus from reactive treatment to preventive, patient-centered care, with AI-driven analytics identifying high-risk patients and addressing care gaps. Patients receive more personalized, effective treatment, rather than a volume treatment driven approach. Better patient outcomes lead to reduced hospitalizations and cost savings, while increased cost monitoring and efficiency for providers supports increased revenue and net income potential. For many patients, the American healthcare system often feels rushed, transactional and fragmented. Doctors have limited time, and treatment decisions can be driven by billing structures rather than patient…

ThursdayFeb 20, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Focused on Advancing Stem Cell-Based Research Amid Rising Cancer Concerns

Rising cancer numbers indicate urgent need for advancements in cancer research, and stem cell research is rising to meet the challenge. Stem cells are being explored not only as a tool to regenerate damaged tissues but also as a delivery vehicle for innovative cancer treatments. Calidi Biotherapeutics stands at the forefront of integrating stem cell technology into oncology. As 2025 approaches, cancer continues to be one of the most significant global health challenges. Projections indicate a sharp increase in cancer diagnoses, with new cases in 2024 expected to surpass 2 million annually in the United States for the first time.…

ThursdayFeb 20, 2025 10:00 am

Scientists Discover ‘Roadmap’ Followed by Aggressive Cancers to Spread

A new study whose findings were published in the Nature Communications journal has shown how tumor cells are changed by the environment around them. Because of these alterations, cancer cells alter their shape, thereby escaping from the tumor and spreading to other parts of the organ or body. The findings of this study have been almost 10 years in the making and they open the door for the development of interventions that could treat cancer prior to its spread. To understand why this study is pivotal, one must understand the structure of a tumor. Tumors are contained within a structure…

FridayFeb 14, 2025 10:00 am

Analysis Uncovers Key Insights About Insurers’ Medical Advantage Prior Authorization Decisions

Nearly all people who enroll for Medical Advantage plans are expected to secure prior authorization when they need certain services, such as skilled nursing facility care, in-patient stays at hospitals and services that cost a lot, such as chemotherapy. A recent analysis revealed critical insights about MA prior authorizations in 2023. We share some of them in the discussion below. 50 million applications were made for prior authorizations The data submitted to CMS shows that insurance firms providing MA coverage made 50 million determinations with regard to prior authorization requests. This number conforms to a pattern of steady growth that…

ThursdayFeb 13, 2025 10:00 am

Ongoing Trial Seeks to Avert Alzheimer’s Decades Before it Strikes

An ongoing clinical trial aims to test a drug that is hoped to avert Alzheimer’s disease decades before it is expected to manifest in an individual. This study is being conducted by a team at the School of Medicine at Washington University. The drug in question, remternetug, was formulated by Eli Lilly and is intended to clear plaque from the brains of young people that have been found to have a genetic predisposition to developing Alzheimer’s disease. The study subjects are young people, some of them 18 years old, expected to develop the disease early (from their 30s onwards). In…

TuesdayFeb 11, 2025 1:35 pm

How Adageis Uses Data to Drive Value-Based Care Adoption and Boost Revenue for Healthcare Providers

Value-based care models prioritize proactive, high-quality patient care, and, if done correctly, can significantly enhance financial outcomes. Healthcare organizations adopting a value-based care approach can see increased revenue through efficiency, reduced hospitalizations and incentive payments. Adageis provides AI-driven solutions that help providers transition to and optimize value-based care models. The company’s data analytics features play a critical role in identifying high-risk patients, closing care gaps and controlling costs. Healthcare is undergoing a major transformation as more organizations shift from fee-for-service to value-based care. Under value-based care models, providers are reimbursed based on patient outcomes rather than the volume of services…

TuesdayFeb 11, 2025 10:00 am

Biomaterial Modification Could Yield Better Cancer Therapies, Study Finds

Altering the physical attributes of tiny biomaterials to enable them to interact more seamlessly with the tissues of the body could result in more effective and safer treatments for cancer. This is according to a team of researchers at Virginia Tech. DaeYong Lee, the head of the team that conducted this research, revealed that making modest changes to biomaterials and nanoparticles used in therapy could one day result in better clinical outcomes for patients. The review focused on an area that has been understudied; the physical attributes, such as particle shape, size and stiffness. These properties play a role in…

FridayFeb 07, 2025 10:00 am

Donald Trump’s Shock at Autism Figures Triggers Discussions on Possible Causes

Writing on Truth Social, President Trump expressed shock at the fact that the current prevalence rate of autism in the U.S. stood at one in thirty-four kids. This is in contrast to the 1 in 1000 kids two decades ago, according to the figures he cited. Why is the prevalence escalating so fast? While it has been suggested that the surge in ASD cases may be due to increased awareness about the condition and improved diagnostics, others point to additional factors that could be causing the uptick in autism cases. Some research posits that increasing chemical contaminants in water and…